Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.
Susan J. Schniepp
Advertisement
Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.
Articles by Susan J. Schniepp
Advertisement
Latest Updated Articles
- Defining Risk Assessment of Aseptic Processes
Published: October 2nd 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
2
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
3
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
4
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
5
